National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Molecular Diagnostics
< Back to Main
In English En español
    Posted: 01/28/2005    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
View/Print PowerPoint  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Slide 25 : SNPs Microarrays Check Drug Metabolism previousnext

Microarrays will also be useful in studying drug metabolism. Drugs are broken down in the body by proteins, and not all of these proteins are identical from person to person. Genetic variations, called single nucleotide polymorphisms (SNPs), can result in subtle differences in proteins that translate to major differences in how the protein functions. For example, as many as 40 percent of people have a SNP that causes a deficiency in a protein called cytochrome P450 CYP2C9, which is important to drug metabolism. Deficiencies in this protein can impair the metabolism of as many as 1 in 5 medications currently on the market.

SNPs Microarrays Check Drug Metabolism

< Previous  |  Index  |  Next Slide >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov